Charles Schwab’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122M Buy
2,335,117
+98,361
+4% +$3.84M 0.02% 671
2026
Q1
$79.1M Buy
2,236,756
+84,000
+4% +$2.61M 0.01% 860
2025
Q4
$60.2M Buy
2,152,756
+12,383
+0.6% +$371K 0.01% 1028
2025
Q3
$64.2M Buy
2,140,373
+48,324
+2% +$1.36M 0.01% 988
2025
Q2
$59.9M Buy
2,092,049
+44,646
+2% +$1.33M 0.01% 987
2025
Q1
$67.6M Sell
2,047,403
-21,558
-1% -$703K 0.01% 866
2024
Q4
$59.5M Sell
2,068,961
-38,088
-2% -$1.09M 0.01% 1006
2024
Q3
$59M Sell
2,107,049
-275,518
-12% -$7.35M 0.01% 1007
2024
Q2
$57.4M Buy
2,382,567
+45,662
+2% +$1.12M 0.01% 961
2024
Q1
$63.3M Buy
2,336,905
+189,783
+9% +$5.39M 0.01% 853
2023
Q4
$59.6M Sell
2,147,122
-15,076
-0.7% -$392K 0.02% 855
2023
Q3
$60.6M Buy
2,162,198
+114,388
+6% +$3.35M 0.02% 765
2023
Q2
$64.1M Buy
2,047,810
+98,997
+5% +$3M 0.02% 715
2023
Q1
$54.9M Sell
1,948,813
-22,190
-1% -$605K 0.02% 771
2022
Q4
$51.5M Buy
1,971,003
+46,708
+2% +$1.12M 0.02% 791
2022
Q3
$43M Buy
1,924,295
+49,206
+3% +$1.28M 0.02% 855
2022
Q2
$55.9M Sell
1,875,089
-54,324
-3% -$1.56M 0.02% 683
2022
Q1
$50.8M Buy
1,929,413
+56,188
+3% +$1.39M 0.02% 860
2021
Q4
$43.6M Sell
1,873,225
-61,454
-3% -$1.62M 0.01% 992
2021
Q3
$59.7M Buy
1,934,679
+341,464
+21% +$9.65M 0.02% 756
2021
Q2
$39.1M Buy
1,593,215
+375,454
+31% +$8.35M 0.01% 1053
2021
Q1
$22.7M Buy
1,217,761
+31,713
+3% +$649K 0.01% 1419
2020
Q4
$23.7M Buy
1,186,048
+18,739
+2% +$343K 0.01% 1276
2020
Q3
$19.3M Sell
1,167,309
-12,445
-1% -$226K 0.01% 1225
2020
Q2
$22.9M Buy
1,179,754
+33,515
+3% +$544K 0.01% 1079
2020
Q1
$16.5M Sell
1,146,239
-1,762
-0.2% -$31.5K 0.01% 1140
2019
Q4
$23.4M Buy
1,148,001
+52,003
+5% +$1.03M 0.01% 1098
2019
Q3
$21.4M Buy
1,095,998
+335,338
+44% +$7.3M 0.01% 1101
2019
Q2
$17.1M Buy
760,660
+51,881
+7% +$1.42M 0.01% 1242
2019
Q1
$25.9M Buy
708,779
+90,283
+15% +$2.98M 0.02% 950
2018
Q4
$18.3M Buy
618,496
+26,790
+5% +$987K 0.01% 1049
2018
Q3
$25.1M Buy
591,706
+24,508
+4% +$1.06M 0.02% 999
2018
Q2
$23.3M Buy
567,198
+30,410
+6% +$1.38M 0.02% 970
2018
Q1
$31.1M Buy
536,788
+43,273
+9% +$2.53M 0.02% 719
2017
Q4
$27M Buy
493,515
+23,712
+5% +$1.21M 0.02% 765
2017
Q3
$23.9M Buy
469,803
+20,999
+5% +$1.12M 0.02% 794
2017
Q2
$26M Buy
448,804
+6,484
+1% +$377K 0.02% 680
2017
Q1
$25.9M Buy
442,320
+39,213
+10% +$2.22M 0.03% 660
2016
Q4
$22.4M Buy
403,107
+17,643
+5% +$943K 0.02% 687
2016
Q3
$18.1M Buy
385,464
+20,625
+6% +$981K 0.02% 749
2016
Q2
$15.8M Buy
364,839
+43,630
+14% +$1.8M 0.02% 780
2016
Q1
$11M Buy
321,209
+6,103
+2% +$241K 0.01% 984
2015
Q4
$25M Buy
315,106
+23,126
+8% +$1.62M 0.03% 505
2015
Q3
$17.1M Sell
291,980
-81,975
-22% -$5.41M 0.03% 624
2015
Q2
$24.1M Buy
373,955
+24,556
+7% +$1.5M 0.03% 501
2015
Q1
$21.3M Buy
349,399
+34,959
+11% +$2.39M 0.03% 531
2014
Q4
$18.4M Buy
314,440
+29,109
+10% +$1.48M 0.03% 547
2014
Q3
$12.2M Buy
285,331
+5,310
+2% +$238K 0.02% 676
2014
Q2
$14.1M Sell
280,021
-26,850
-9% -$1.24M 0.02% 613
2014
Q1
$13.5M Buy
306,871
+64,506
+27% +$3.07M 0.02% 616
2013
Q4
$9.86M Buy
242,365
+22,014
+10% +$813K 0.02% 731
2013
Q3
$7.29M Buy
220,351
+23,745
+12% +$773K 0.01% 856
2013
Q2
$5.8M Buy
+196,606
New +$5.73M 0.01% 923

Other funds holding ALKS

Charles Schwab's ALKS Position: Q2 2026 in Review

Charles Schwab increased its Alkermes (ALKS) stake by 4.4% in Q2 2026, buying an estimated $3.84M and bringing the position to 2,335,117 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #671.

Charles Schwab first reported a position in ALKS in Q2 2013 and has held it in 53 quarters since. 423 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Charles Schwab held 2,335,117 shares of Alkermes worth $122M as of Q2 2026.
  • Charles Schwab bought 98,361 Alkermes shares in Q2 2026, an estimated $3.84M.
  • Alkermes made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #671 holding.
  • Charles Schwab first reported a position in Alkermes in Q2 2013 and has held it in 53 quarters since.
  • 423 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.